|
Characteristic
|
OR (95% CI)
|
L-R Chi-Square
|
P-Value
|
|---|
|
Survey Year
| |
68.2
|
< 0.001
|
|
1996
|
1.00 (reference)
| | |
|
1997
|
1.02 (0.63–1.58)
| | |
|
1998
|
1.25 (0.80–1.89)
| | |
|
1999
|
1.05 (0.65–1.65)
| | |
|
2000
|
0.74 (0.43–1.21)
| | |
|
2001
|
1.19 (0.76–1.83)
| | |
|
2002
|
0.98 (0.61–1.54)
| | |
|
2003
|
1.94 (1.29–2.85)
| | |
|
2004
|
0.59 (0.35–0.96)
| | |
|
2005
|
0.37 (0.19–0.66)
| | |
|
2006
|
0.64 (0.38–1.05)
| | |
|
Race
| |
0.9
|
0.3
|
|
White
|
1.00 (reference)
| | |
|
Black
|
1.07 (0.93–1.25)
| | |
|
Age (years)
| |
12.8
|
0.005
|
|
18–34
|
1.00 (reference)
| | |
|
35–49
|
0.66 (0.51–0.86)
| | |
|
50–64
|
0.77 (0.55–1.08)
| | |
|
≥ 65
|
3.06 (1.65–5.37)
| | |
|
Gender
| |
2.7
|
0.9
|
|
Female
|
1.00 (reference)
| | |
|
Male
|
1.14 (0.98–1.34)
| | |
|
Insurance Status
| |
3.8
|
0.4
|
|
Uninsured
|
1.00 (reference)
| | |
|
Government
|
0.81 (0.63–1.07)
| | |
|
Private
|
0.76 (0.55–1.04)
| | |
|
Other insurance
|
1.57 (0.85–2.74)
| | |
|
Presence of Comorbidities*
| | | |
|
Preventable OI
|
2.39 (2.00–2.83)
|
86.9
|
< 0.001
|
|
Non-preventable OI
|
1.16 (0.98–1.37)
|
3.1
|
0.08
|
|
HBV
|
0.86 (0.54–1.31)
|
0.5
|
0.5
|
|
HCV
|
0.85 (0.64–1.11)
|
1.3
|
0.2
|
|
Cocaine use
|
0.46 (0.32–0.80)
|
25.2
|
< 0.001
|
- *Reference group is the absence of a comorbidity where OR = 1.00
